Related references
Note: Only part of the references are listed.The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone
Lihi Eder et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab
Carrie L. Wagner et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Update on Biomarkers in Psoriatic Arthritis: A Report from the GRAPPA 2010 Annual Meeting
O. FITZGERALD et al.
JOURNAL OF RHEUMATOLOGY (2012)
Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study
V. Modesti et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)
Future Trends in Research in Psoriatic Arthritis
Dafna D. Gladman
JOURNAL OF RHEUMATOLOGY (2012)
Prevalence of spondyloarthritis and its subtypes in southern Sweden
E. Haglund et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Atherosclerosis in psoriatic arthritis
R. Ramonda et al.
AUTOIMMUNITY REVIEWS (2011)
Increased serum TWEAK levels in Psoriatic arthritis: Relationship with disease activity and matrix metalloproteinase-3 serum levels
Liping Xia et al.
CYTOKINE (2011)
Effects of Long-Term Disease-Modifying Antirheumatic Drugs on Endothelial Function in Patients with Early Rheumatoid Arthritis
M. Turiel et al.
CARDIOVASCULAR THERAPEUTICS (2010)
Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors
Susanne Juhl Pedersen et al.
CLINICAL RHEUMATOLOGY (2010)
Soluble Biomarkers of Cartilage and Bone Metabolism in Early Proof of Concept Trials in Psoriatic Arthritis: Effects of Adalimumab Versus Placebo
Arno W. R. van Kuijk et al.
PLOS ONE (2010)
Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis
Vinod Chandran et al.
RHEUMATOLOGY (2010)
Sustained improvement of vascular endothelial function during anti-TNF treatment in rheumatoid arthritis patients
P. I. Sidiropoulos et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2009)
Subclinical carotid atherosclerosis in patients with psoriatic arthritis
Lai-Shan Tam et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis
B. Strober et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review
W. Sterry et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis
F. Del Porto et al.
RHEUMATOLOGY (2007)
Establishment of a high sensitivity plasma assay for human Pentraxin3 as a marker for unstable angina pectoris
Kenji Inoue et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?
D. D. Gladman
ANNALS OF THE RHEUMATIC DISEASES (2006)
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
William Taylor et al.
ARTHRITIS AND RHEUMATISM (2006)
Cytokine profiles during infliximab monotherapy in psoriatic arthritis
A Mastroianni et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Antiangiogenic effects of anti-tumor necrosis factor a therapy with infliximab in psoriatic arthritis
JD Cañete et al.
ARTHRITIS AND RHEUMATISM (2004)
Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate
D Kane et al.
ARTHRITIS AND RHEUMATISM (2004)
Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor α antibody
C Gonzalez-Juanatey et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction
R Latini et al.
CIRCULATION (2004)
High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies
M Drouart et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study
CA Labarrere et al.
LANCET (2002)
Production of the long pentraxin PTX3 in advanced atherosclerotic plaques
MS Rolph et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment
C Ribbens et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Share Paper
